US Physiological Saline Market to Grow at a CAGR of 6.2% to reach US$ 3,910.28 million from 2022 to 2030
分析师观点
美国生理盐水市场分析解释了严重疾病和液体电解质紊乱患病率上升以及液体需求激增等市场驱动因素老年人群的电解质。此外,医院环境中的大规模生理盐水需求预计将成为 2022 年至 2030 年市场的新趋势。美国生理盐水市场按类型分为生理盐水、高渗盐水、低渗盐水和平衡盐水。生理盐水细分市场在 2022 年占据最大的市场份额。然而,高渗盐水细分市场预计在预测期内复合年增长率最高。美国生理盐水市场按包装类型分为软袋、塑料瓶和玻璃瓶。塑料瓶细分市场在 2022 年占据最大的市场份额。预计软袋细分市场在 2022 年至 2030 年期间复合年增长率最高。按应用划分,美国生理盐水市场分为静脉注射、眼科、伤口护理、内窥镜检查、皮肤擦伤等。静脉注射细分市场在 2022 年占据最大的市场份额,预计该细分市场在 2022 年至 2030 年期间复合年增长率最高。美国生理盐水市场按给药途径分为静脉注射和局部注射。静脉注射细分市场在 2022 年占据更大的市场份额,预计该细分市场在 2022 年至 2030 年期间将实现更高的复合年增长率。按最终用户划分,美国生理盐水市场分为医院、专科诊所、门诊手术中心、家庭护理等。医院细分市场在 2022 年占据最大的市场份额。预计专科诊所细分市场在 2022 年至 2030 年期间复合年增长率最高。
生理盐水溶液由等渗且具有相同 pH 值的盐溶液组成。生理盐水溶液的一个例子是林格氏溶液,其由氯化钠(NaCl)、碳酸氢钠和氯化钾溶液的混合物组成。在患者出现脱水、液体失衡和更多临床异常的情况下,医生推荐使用生理盐水。
市场洞察
严重疾病和液体电解质紊乱患病率上升推动美国生理盐水市场
根据高级姑息治疗中心的一份报告,约 9000 万美国人患有严重疾病,预计未来 25 年这一数字将增加一倍以上。此外,国家卫生委员会的一份报告显示,近 1.33 亿美国人受到无法治愈和持续存在的慢性病的影响,占全国总人口的 40% 以上。其中,近 50% 的成年人和近 8% 的 5-17 岁儿童患有慢性病。美国国家卫生委员会的报告还提到,美国人罹患不治之症的慢性病病例不断增加,导致医疗费用约占医疗费用的75%。
严重疾病会导致体液失衡,例如钾、镁、钙水平低下,以及体内的钠。体液水平不当会对身体功能、肌肉力量和心律产生负面影响,这与肾脏或内分泌腺疾病有关。例如,当身体保持过多的体液水平时,就会发生水肿,导致患者的面部、手臂、腿、手和脚肿胀和疼痛。此外,失去的体液多于消耗的量会导致脱水,表现出一系列症状,例如口渴、虚弱、头晕、昏厥和尿量减少。因此,慢性疾病可能会导致患者体内体液失衡,从而推动对作为治疗一部分的生理盐水的需求。因此,严重疾病和液体电解质紊乱患病率的上升促进了美国生理盐水市场的增长。
未来趋势
医院环境中的大规模生理盐水需求
根据发布的报告根据英国皇家化学学会的规定,使用盐水溶液清洗红细胞 (RBC) 和治疗危重患者是医院环境中的常见做法。临床研究小组审查了在不同临床环境中使用生理盐水(0.9% NaCl)的安全性,并建议使用盐水溶液是医院环境中最安全的技术之一。例如,在输血医学中,盐水溶液用于清洗细胞和在血浆分离术以及失血或失液患者复苏的情况下进行抢救程序。清洗红细胞需要 1-2 L 无菌盐水溶液。在单采术中,盐水溶液用于治疗性血浆交换程序和术中细胞回收以洗涤红细胞。因此,生理盐水在医院环境中大规模的多方面应用很可能成为美国生理盐水市场的新趋势。
报告细分和范围
市场机会
使用低速快速样本运输成本盐溶液
一种更便宜且容易获得的盐溶液可用于安全运输测试样本,从而能够更有效地将样本长距离运输到诊断实验室。一种现成的盐溶液,例如“磷酸盐缓冲盐水”,一种医院和临床实验室常见的简单盐溶液,被用作冠状病毒污染标本的运输介质;盐水可使样品保持稳定长达 18 小时。在 COVID-19 大流行期间,病毒运输介质的短缺给从 COVID-19 患者身上获取的标本运输到诊断和测试实验室带来了重大挑战,从而导致对无菌盐溶液的需求激增。因此,研究人员建议使用廉价且常见的盐溶液(例如磷酸盐缓冲盐溶液)进行运输。因此,人们对更便宜且容易获得的盐溶液的认识不断提高,及其在医学标本运输中的使用可能会在 2022 年至 2030 年期间为美国生理盐水市场提供机会。
基于类型的见解
美国生理盐水市场按类型分为生理盐水、高渗盐水、低渗盐水和平衡盐水。生理盐水细分市场在 2022 年占据最大的市场份额。生理盐水 (NS) 包括用于短期补液的无菌盐溶液,因为它有助于恢复体内的电解质/盐水平。它是一种 0.9% 的氯化钠溶液,旨在治疗人们的脱水和电解质紊乱。 NS 是临床中常用的静脉注射液的基石。它适用于儿童和成人患者群体。使用经美国食品和药物管理局 (FDA) 批准的 NS 溶液的主要适应症如下:
细胞外液替代治疗脱水、低血容量、出血、败血症等。存在以下情况时治疗代谢性碱中毒液体流失轻度钠缺乏此外,NS只能通过静脉注射给药,生理盐水的管理需要评估患者的健康状况。药剂师需要在安装时监控静脉输液的实施情况,并根据患者的临床情况建议订购,并就剂量和给药方面向医院护理部门进行适当咨询。
基于包装类型的见解
美国生理盐水市场按包装类型分为软袋、塑料瓶和玻璃瓶。塑料瓶细分市场将在 2022 年占据更大的市场份额,预计软袋细分市场在预测期内的复合年增长率最高。注射用氯化钠 (NaCl) USP 溶液是无菌且无热原的。它们是注射用水 (WFI) 中含有不同浓度 NaCl 的肠胃外溶液,用于静脉 (IV) 给药。此外,柔性容器由特殊配方的聚氯乙烯制成。然而,与塑料容器接触的溶液可能会从塑料中滤出极少量的某些化学成分。此外,生物测试证明可以有效支持塑料容器材料的安全性。因此,预计塑料瓶在预测期内将占生理盐水市场的最小份额。
基于应用的见解
美国生理盐水市场按应用细分为静脉注射、眼科、伤口护理、内窥镜检查、皮肤擦伤等。静脉注射细分市场在 2022 年占据更大的市场份额,预计该细分市场在预测期内复合年增长率最高。静脉 (IV) 盐水溶液配制用于预防或治疗脱水。各个年龄段的医生都会为受伤、生病、脱水或接受手术的人开静脉注射生理盐水。盐水静脉注射袋提供了一种快速且有针对性的解决方案来补充液体和缓解症状。此外,无菌水和氯化钠或盐和生理盐水静脉注射的组合有助于恢复患者的体液平衡和水合组织。当患者需要水合作用时,通常会向患者的血液中注入静脉注射盐水。它被认为是对特定药物过敏或敏感的人的合适选择。
多家公司正在生产与静脉注射盐水相关的创新产品;例如,Fresenius Kabi USA 提供“freeflex”和“freeflex+ IV 袋”。这些产品还提供防漏、无菌保护和针刺预防功能。
基于给药途径的见解
美国生理盐水市场按给药途径分为静脉注射和局部给药。静脉注射细分市场在 2022 年占据更大的市场份额,预计该细分市场在预测期内复合年增长率最高。静脉注射盐水溶液是专门配制的液体,注入静脉以预防和治疗脱水。此外,这些静脉输液适用于患有疾病、受伤、脱水等的所有年龄段的人。静脉注射生理盐水是一种简单、安全、常见的手术,并发症风险较低。此外,液体复苏是急症患者治疗的重要组成部分,生理盐水被认为是重病或受伤患者最广泛使用的静脉输液。作为一种常见、简单且安全的手术,通过静脉注射途径给药的患者可能会在短时间内感到缓解。
美国生理盐水市场,按类型 - 2022 年和 2030 年
国家分析
美国生理盐水预计到 2030 年,静脉注射液市场将从 2022 年的 24.1258 亿美元增至 39.1028 亿美元。美国 FDA 正在积极与 Fresenius Kabi 和 Grifols 等制造商合作,通过支持静脉 (IV) 注射液的严重短缺问题。扩大他们的生产能力。 FDA 还重点关注盐水进口,以解决严重短缺问题。此外,根据国家生物技术信息中心的报告,美国每年销售近 2 亿升盐水。根据同一份报告,全国各地每天向患者注射超过 100 万升 0.9% 氯化钠。此外,根据JAMA Network的报告,美国的外科手术数量激增,从2020年进行的3,156,240例手术中可以看出这一点。因此,随着外科手术数量的增加,对生理盐水的需求也随之增加。美国的解决方案也在增加。
在 COVID-19 大流行期间,美国的医院环境对生理盐水的需求量很大。为了解决严重的短缺问题,医院寻找替代解决方案,例如 5% 葡萄糖水溶液、5% 葡萄糖与较低浓度的 NaCl 以及 5% 葡萄糖乳酸林格注射液,以满足关键需求。此类生理盐水替代品帮助他们克服了 COVID-19 大流行期间供需缺口带来的挑战。
该报告介绍了在美国生理盐水市场运营的领先企业。这些公司包括 Fresenius Kabi AG、Merck KGaA、AdipoGen Life Sciences Inc、Enzo Life Sciences Inc、ICU Medical Inc、Grifols SA、Geno Technology Inc、B Braun Medical Inc、Pfizer Inc 和 Ward's Science。
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
Frequently Asked Questions
A physiological saline solution is composed of salt solutions that are isotonic and have the same pH. An example of physiological saline solution is Ringer's solution, composed of a mixture of sodium chloride (NaCl), sodium bicarbonate, and potassium chloride solution. The physiological solution is recommended by the physician in case of dehydration, fluid imbalances, and many more clinical abnormalities among the patients.
The CAGR value of the US Physiological Saline during the forecasted period of 2022-2030 is 6.2%.
The normal saline segment held the largest market share in 2022 segment in the US physiological saline.
The plastic bottle segment dominated the US physiological saline and held the largest market share in 2022.
Fresenius Kabi AG and ICU Medical Inc are the top two companies that hold huge market shares in the US physiological saline market.
The US physiological saline majorly consists of the players such Fresenius Kabi AG, Merck KGaA, AdipoGen Life Sciences Inc, Enzo Life Sciences Inc, ICU Medical Inc, Grifols SA, Geno Technology Inc, B Braun Medical Inc, Pfizer Inc, and Ward's Science, and among others. .
Key factors that are driving the growth of this market are rising prevalence of serious illnesses and fluid electrolyte disorders to boost the market growth for the US physiological saline over the years.
The List of Companies - US Physiological Saline Market
- Fresenius Kabi AG
- Merck KGaA
- AdipoGen Life Sciences Inc
- Enzo Life Sciences Inc
- ICU Medical Inc
- Grifols SA
- Geno Technology Inc
- B Braun Medical Inc
- Pfizer Inc
- Ward's Science
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.